Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Global Spine Journal|May 26, 2018
Publication Rate of Podium Presentations From the North American Spine Society Annual MeetingsBrandon Raudenbush, Chelsea Frost, Richard Okafor, et al.
Expert Opinion on Pharmacotherapy|May 23, 2023
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathyMadeline Merkel, David Danese, Chongshu Chen, et al.
Shanghai Archives of Psychiatry|August 4, 2017
Win Ratio -An Intuitive and Easy-To-Interpret Composite Outcome in Medical StudiesHongyue Wang, Jing Peng, Juila Z Zheng, et al.
Therapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Journal of the American College of Cardiology|March 18, 2025
Impact of Vutrisiran on Functional Capacity and Quality of Life in Transthyretin Amyloidosis With CardiomyopathyFarooq H Sheikh, Gilbert Habib, W H Wilson Tang, et al.
JACC. Asia|May 21, 2026
Vutrisiran in East Asian Patients With Transthyretin Amyloidosis With Cardiomyopathy: Post-Hoc Analysis of HELIOS-BJin Endo, Tetsuo Minamino, Jaewon Oh, et al.
Fertility and Sterility|March 10, 2015
Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling womenEmily S Barrett, Chongshu Chen, Sally W Thurston, et al.
Neurology and Therapy|July 31, 2023
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyLaura Obici, Senda Ajroud-Driss, Kon-Ping Lin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2020
Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunityErin E Longbrake, Yang Mao-Draayer, Mark Cascione, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
Pageof 2